interleukin-1beta (163-171) has been researched along with n-formylmethionine leucyl-phenylalanine in 1 studies
| Studies (interleukin-1beta (163-171)) | Trials (interleukin-1beta (163-171)) | Recent Studies (post-2010) (interleukin-1beta (163-171)) | Studies (n-formylmethionine leucyl-phenylalanine) | Trials (n-formylmethionine leucyl-phenylalanine) | Recent Studies (post-2010) (n-formylmethionine leucyl-phenylalanine) |
|---|---|---|---|---|---|
| 192 | 3 | 74 | 6,716 | 53 | 356 |
| Protein | Taxonomy | interleukin-1beta (163-171) (IC50) | n-formylmethionine leucyl-phenylalanine (IC50) |
|---|---|---|---|
| fMet-Leu-Phe receptor | Homo sapiens (human) | 0.02 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexander, JW; Balasurbramaniam, A; Noel, JG; Ogle, CK; Ogle, JD; Sramkoski, RM | 1 |
1 other study(ies) available for interleukin-1beta (163-171) and n-formylmethionine leucyl-phenylalanine
| Article | Year |
|---|---|
Comparison of abilities of recombinant interleukin-1 alpha and -beta and noninflammatory IL-1 beta fragment 163-171 to upregulate C3b receptors (CR1) on human neutrophils and to enhance their phagocytic capacity.
Topics: Antigens, CD; Humans; In Vitro Techniques; Interleukin-1; Interleukin-1beta; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Peptide Fragments; Phagocytosis; Receptors, Complement; Receptors, Complement 3b; Recombinant Proteins; Stimulation, Chemical; Up-Regulation | 1990 |